Hologic, Inc. (LON:0J5Q)

Hologic Statistics

Total Valuation

Hologic has a market cap or net worth of GBP 11.60 billion. The enterprise value is 12.08 billion.

Market Cap	11.60B
Enterprise Value	12.08B

Important Dates

The next estimated earnings date is Monday, November 3, 2025.

Earnings Date	Nov 3, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	222.42M
Shares Outstanding	n/a
Shares Change (YoY)	-4.25%
Shares Change (QoQ)	-0.14%
Owned by Insiders (%)	0.84%
Owned by Institutions (%)	99.60%
Float	220.37M

Valuation Ratios

The trailing PE ratio is 28.55 and the forward PE ratio is 15.71.

PE Ratio	28.55
Forward PE	15.71
PS Ratio	3.94
PB Ratio	3.28
P/TBV Ratio	28.59
P/FCF Ratio	17.07
P/OCF Ratio	14.88
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 12.61, with an EV/FCF ratio of 17.77.

EV / Earnings	29.73
EV / Sales	4.00
EV / EBITDA	12.61
EV / EBIT	17.22
EV / FCF	17.77

Financial Position

The company has a current ratio of 3.55, with a Debt / Equity ratio of 0.52.

Current Ratio	3.55
Quick Ratio	2.59
Debt / Equity	0.52
Debt / EBITDA	1.96
Debt / FCF	2.71
Interest Coverage	7.86

Financial Efficiency

Return on equity (ROE) is 11.38% and return on invested capital (ROIC) is 7.95%.

Return on Equity (ROE)	11.38%
Return on Assets (ROA)	6.69%
Return on Invested Capital (ROIC)	7.95%
Return on Capital Employed (ROCE)	12.07%
Revenue Per Employee	416,979
Profits Per Employee	57,515
Employee Count	7,063
Asset Turnover	0.46
Inventory Turnover	2.29

Taxes

In the past 12 months, Hologic has paid 86.41 million in taxes.

Income Tax	86.41M
Effective Tax Rate	17.54%

Stock Price Statistics

The stock price has decreased by -19.91% in the last 52 weeks. The beta is 0.63, so Hologic's price volatility has been lower than the market average.

Beta (5Y)	0.63
52-Week Price Change	-19.91%
50-Day Moving Average	66.97
200-Day Moving Average	64.64
Relative Strength Index (RSI)	60.52
Average Volume (20 Days)	264

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	1.64

Income Statement

In the last 12 months, Hologic had revenue of GBP 2.95 billion and earned 406.23 million in profits. Earnings per share was 1.76.

Revenue	2.95B
Gross Profit	1.79B
Operating Income	690.18M
Pretax Income	492.64M
Net Income	406.23M
EBITDA	910.54M
EBIT	690.18M
Earnings Per Share (EPS)	1.76

Balance Sheet

The company has 1.37 billion in cash and 1.84 billion in debt, giving a net cash position of -466.10 million.

Cash & Cash Equivalents	1.37B
Total Debt	1.84B
Net Cash	-466.10M
Net Cash Per Share	n/a
Equity (Book Value)	3.53B
Book Value Per Share	15.89
Working Capital	1.79B

Cash Flow

In the last 12 months, operating cash flow was 779.50 million and capital expenditures -99.83 million, giving a free cash flow of 679.68 million.

Operating Cash Flow	779.50M
Capital Expenditures	-99.83M
Free Cash Flow	679.68M
FCF Per Share	n/a

Margins

Gross margin is 60.86%, with operating and profit margins of 23.43% and 13.79%.

Gross Margin	60.86%
Operating Margin	23.43%
Pretax Margin	16.73%
Profit Margin	13.79%
EBITDA Margin	30.92%
EBIT Margin	23.43%
FCF Margin	23.08%

Dividends & Yields

Hologic does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	4.25%
Shareholder Yield	4.25%
Earnings Yield	3.50%
FCF Yield	5.86%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Hologic has an Altman Z-Score of 4.13 and a Piotroski F-Score of 6.

Altman Z-Score	4.13
Piotroski F-Score	6